2025 annual financial data
Silexion Therapeutics 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was 11,632,000 USD and net income was -11,912,000 USD.
Operating cash flow was -10,819,000 USD.
Get free Silexion Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- 11,632,000 USD
- Net income
- -11,912,000 USD
- Operating cash flow
- -10,819,000 USD